guide
Antifungal Ingredients: Terbinafine, Clotrimazole, Miconazole & Tolnaftate
Compare terbinafine, clotrimazole, miconazole and tolnaftate by infection type, body site, formulation, course and important use limits.
Open decision guide →Decision library
Plain-English guides to treatment evidence, technical specifications, skin-care ingredients, eczema creams, supplements, diets and other high-friction health-product decisions.
guide
Compare terbinafine, clotrimazole, miconazole and tolnaftate by infection type, body site, formulation, course and important use limits.
Open decision guide →guide
How petrolatum, dimethicone, glycerin, ceramides and fragrance-free formulations overlap across dry skin, eczema and contact dermatitis—and where that overlap stops.
Open decision guide →guide
Compare oat and yeast beta-glucans, larch arabinogalactan, acacia and GOS by molecular form, retail dose, human outcomes and evidence-transfer limits.
Open decision guide →guide
Evidence-based guide to intravaginal boric acid for selected recurrent or non-albicans vulvovaginal candidiasis, with strong route and safety boundaries.
Open decision guide →guide
Review Candida-diet and cleanse claims about sugar, probiotics, oregano oil, caprylic acid, garlic and fermented foods, with treatment and safety limits.
Open decision guide →guide
Compare popular Candida supplements by human clinical evidence, adjunctive findings, laboratory data, safety limits and unsupported cure claims.
Open decision guide →guide
How vaginal samples, oral examination, endoscopy and blood cultures are used for candidiasis, plus the limits of stool, antibody and wellness panels.
Open decision guide →Ingredient comparison
Compare the main ingredient types used for dry, cracked heels: urea, salicylic acid, alpha-hydroxy acids, petrolatum and thick fragrance-free moisturizers.
Open decision guide →Topical treatment comparison
Understand the main eczema cream classes: moisturizers, topical corticosteroids, calcineurin inhibitors, PDE-4, JAK and AhR treatments—plus what each class can and cannot do.
Open decision guide →Root-cause evidence
What causes atopic dermatitis, when food allergy or GI symptoms warrant investigation, and where microbiome, IgG, detox and probiotic claims exceed the evidence.
Open decision guide →Gut-skin evidence
How food allergy, elimination diets, probiotics, microbiome tests and vitamin D relate to eczema, including evidence limits and when targeted evaluation makes sense.
Open decision guide →guide
A practical essential-oil decision guide focused on aroma, bottle transparency, route of use and safety boundaries rather than unsupported treatment promises.
Open decision guide →guide
How multivitamin needs and formulas differ for children, adult men and women, pregnancy, postnatal life and older adults, with evidence-led product examples.
Open decision guide →guide
Side-by-side, prescription-label-based comparison of common onychomycosis treatment pathways by route, treatment duration, nail scope, practical burden and safety considerations.
Open decision guide →Newsletter
A Homeapotherapy newsletter is coming soon.
Open decision guide →guide
Oat beta-glucan for cholesterol: human gram-dose evidence, OatWell label matching, microbiome findings and why yeast beta-glucan is a different ingredient.
Open decision guide →guide
Compare psyllium, acacia, PHGG, resistant maltodextrin and resistant starch for constipation by stool outcomes, population, human dose and tolerability.
Open decision guide →guide
Start with the outcome you care about, then compare prebiotic fibers and products by human evidence, dose and tolerability rather than microbiome marketing.
Open decision guide →guide
Compare XOS, GOS, FOS, HMOs, resistant starch and arabinogalactan by human evidence for Bifidobacterium and microbiome changes—without confusing those changes with symptom relief.
Open decision guide →guide
Compare PHGG, GOS, XOS, inulin, FOS and HMOs for IBS and bloating by symptom evidence, fermentation burden and human trial dose.
Open decision guide →guide
Review XOS, resistant starch, Fibersol-2 and HMOs for glucose, insulin resistance, satiety and weight claims, including important null and subgroup results.
Open decision guide →guide
Compare XOS, FOS, GOS, PHGG, resistant maltodextrin, acacia, HMOs, resistant starch, inulin, psyllium and beta-glucans by human dose, outcome and tolerability.
Open decision guide →guide
How to compare prenatal vitamins and DHA using folate, iron, iodine, choline, vitamin D, omega-3 content, product quality and supply-chain transparency.
Open decision guide →guide
Evidence-first guide to probiotics during and after antibiotics, including S. boulardii, Bio-K+, practitioner formulas, C. difficile guidance and why 'restore the microbiome' is too broad a claim.
Open decision guide →guide
How to compare probiotic strains, prebiotic substrates including XOS, FOS, PHGG, GOS, acacia, HMOs and resistant starch, synbiotics and digestive enzymes using indication-specific trials, dose matching and safety.
Open decision guide →guide
Compare probiotic strains and products for antibiotic use, IBS, pouchitis and general gut health by strain identity, dose, population, outcome and safety.
Open decision guide →guide
Evidence-based guide to recurrent vulvovaginal candidiasis, including diagnosis, culture/speciation, non-albicans Candida, suppressive therapy, resistance and common mimics.
Open decision guide →guide
How to compare red-light panel dimensions, wavelengths, irradiance, electrical power, beam angle, controls and regulatory claims without mixing unlike measurements.
Open decision guide →guide
Evidence-based guide to red and blue light for acne vulgaris, including inflammatory acne, studied wavelengths, treatment limits and how light therapy compares with standard acne care.
Open decision guide →guide
Evidence-based review of photobiomodulation for burns and burn wound healing, including the current weak evidence base, studied wavelengths and when burns need urgent care.
Open decision guide →guide
Evidence-based guide to transcranial photobiomodulation for cognition, memory and attention, including studied near-infrared wavelengths, trial results, device geometry and safety limits.
Open decision guide →guide
Evidence-based guide to red and infrared photobiomodulation for diabetic foot ulcers, including studied wavelengths, adjunctive treatment evidence and urgent safety considerations.
Open decision guide →guide
Red and near-infrared photobiomodulation for pattern hair loss: studied wavelengths, treatment geometry, dose limits and where the evidence stops.
Open decision guide →guide
Photobiomodulation for knee osteoarthritis: studied wavelengths, pain and function outcomes, dose uncertainty, adjunctive use and safety limits.
Open decision guide →guide
What photobiomodulation studies actually show about red and near-infrared light for exercise recovery, soreness and fatigue—and why there is no single proven optimal wavelength.
Open decision guide →guide
Photobiomodulation for musculoskeletal pain and sports injury: studied wavelengths, pain and return-to-activity outcomes, protocol differences and safety limits.
Open decision guide →guide
Evidence-based guide to photobiomodulation for pressure ulcers and pressure injuries, including studied red wavelengths, evidence quality and why pressure relief remains essential.
Open decision guide →guide
Clear evidence guide to red-light and LED photobiomodulation for psoriasis, eczema, herpes and other skin conditions, including where evidence is weak and how PBM differs from UV phototherapy.
Open decision guide →guide
A cautious guide to red and near-infrared photobiomodulation for sleep and relaxation, including studied wavelengths, trial limitations and what remains unknown.
Open decision guide →guide
Evidence-based guide to near-infrared and red-light photobiomodulation after surgery, including wound healing, postoperative pain, wavelength ranges and safety limits.
Open decision guide →guide
Current evidence on photobiomodulation for venous leg ulcers, including the 2026 meta-analysis, wavelength uncertainty and why compression and vascular care remain central.
Open decision guide →guide
Professional guide to red and near-infrared photobiomodulation for wrinkles, skin rejuvenation and photoaging, with evidence limits, wavelength context and comparison with established skin care.
Open decision guide →guide
How to interpret red-light irradiance, fluence, exposure time, distance, treatment area and measurement method without turning a device specification into a treatment prescription.
Open decision guide →guide
Evidence-based guide to red light and near-infrared photobiomodulation by condition, including hair loss, joint pain, muscle recovery, acne, skin conditions, wounds, sleep and cognition.
Open decision guide →guide
Compare red-light wavelengths for hair loss, knee pain, muscle recovery, acne, skin aging, wounds, sleep and cognition while keeping dose and device geometry visible.
Open decision guide →guide
Compare seborrheic dermatitis, scalp psoriasis and eczema by scale pattern, distribution, product classes, treatment boundaries and signs that need diagnosis.
Open decision guide →guide
Compare multivitamins, prenatal nutrients, probiotics, prebiotics, digestive enzymes and DHA by life stage, defined need, product quality and clinical evidence.
Open decision guide →guide
A source-checked guide to Vollara air-treatment, water-ionizer, hydrogen-water and laundry hardware, with competitor comparisons that keep manufacturer claims and unlike metrics separate.
Open decision guide →guide
Choose heel-care products by skin condition: daily moisturizers for dryness, urea or acids for intact callus, and petrolatum-rich barriers for fissure-prone heels.
Open decision guide →The seaside effect
Some eczema calms dramatically by the sea. Research points to a stack of effects—light, mineral bathing, climate, fewer irritants and a lower stress load—not one magic ingredient.
Open decision guide →guide
Separate minor wounds from diabetic foot ulcers, pressure injuries, venous ulcers, burns and surgical wounds, with escalation signs and red-light evidence limits.
Open decision guide →